Pyrazolo[1,5-a]pyridine-3-boronic acid pinacol ester
Product Information
Molecular Formula
C13H17BN2O2
Molecular Weight
244.10
Description
Pyrazolo[1,5-a]pyridine-3-boronic acid pinacol ester is an extraordinary biomedical agent. Renowned for its distinctive molecular configuration, this compound showcases unparalleled efficacy in combatting specific malignancies, namely lung, breast, and colon cancers. Operating as a pinpointed intervention, it effectively obstructs critical signaling pathways implicated in malignant cell proliferation and viability. In the realm of biomedicine, it harbors immense possibilities for the advancement of precise anti-neoplastic medications.
Synonyms
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine; PYRAZOLO[1,5-A]PYRIDIN-3-YL-BORONIC ACID PINACOL ESTER; PYRAZOLO[1,5-A]PYRIDINE-3-BORONIC ACID PINACOL ESTER; Pyrazolo[1,5-a]pyridin-3-ylboronic acid pinacol ester; 3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine; Pyrazolo[1,5-a]pyridine-3-boronic acid pinacol ester; 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine
IUPAC Name
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=C3C=CC=CN3N=C2
InChI
InChI=1S/C13H17BN2O2/c1-12(2)13(3,4)18-14(17-12)10-9-15-16-8-6-5-7-11(10)16/h5-9H,1-4H3
InChI Key
JAJULIZEUUBTGU-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
244.1383080 g/mol
Monoisotopic Mass
244.1383080 g/mol
Topological Polar Surface Area
35.8Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
319
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021262684-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | 2020-06-22 |
| US-2021078996-A1 | Hpk1 antagonists and uses thereof | 2019-09-13 |
| US-2021078997-A1 | SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROL[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS | 2019-09-13 |
| US-2021078998-A1 | SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS | 2019-09-13 |
| US-2021087189-A1 | SUBSTITUTED ISINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,3-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS | 2019-09-13 |
| US-2021087190-A1 | SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS | 2019-09-13 |
| US-11021481-B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists | 2019-09-13 |
| US-11028085-B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists | 2019-09-13 |
| US-11034694-B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists | 2019-09-13 |
| US-11078201-B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists | 2019-09-13 |
